open.spotify.com/episode/2SmuBfrn45mHyGx8mp6kFa

Preview meta tags from the open.spotify.com website.

Linked Hostnames

1

Thumbnail

Search Engine Appearance

Google

https://open.spotify.com/episode/2SmuBfrn45mHyGx8mp6kFa

Benchtalk 2025: Dyne Therapeutics' CSO Ron Batra describes the company's FORCE platform, and previews big trial scheduled in DMD and DM1 over the next year

Listen to this episode from BiotechTV - News on Spotify. He describes the science behind FORCE, which combines an antigen-binding fragment, a linker and, a payload. The company's DMD program will have a key trial readout before the end of this year, and DM1 will follow in 2026. Both programs could be filed for AA in 2026 with positive data.



Bing

Benchtalk 2025: Dyne Therapeutics' CSO Ron Batra describes the company's FORCE platform, and previews big trial scheduled in DMD and DM1 over the next year

https://open.spotify.com/episode/2SmuBfrn45mHyGx8mp6kFa

Listen to this episode from BiotechTV - News on Spotify. He describes the science behind FORCE, which combines an antigen-binding fragment, a linker and, a payload. The company's DMD program will have a key trial readout before the end of this year, and DM1 will follow in 2026. Both programs could be filed for AA in 2026 with positive data.



DuckDuckGo

https://open.spotify.com/episode/2SmuBfrn45mHyGx8mp6kFa

Benchtalk 2025: Dyne Therapeutics' CSO Ron Batra describes the company's FORCE platform, and previews big trial scheduled in DMD and DM1 over the next year

Listen to this episode from BiotechTV - News on Spotify. He describes the science behind FORCE, which combines an antigen-binding fragment, a linker and, a payload. The company's DMD program will have a key trial readout before the end of this year, and DM1 will follow in 2026. Both programs could be filed for AA in 2026 with positive data.

  • General Meta Tags

    15
    • title
      Benchtalk 2025: Dyne Therapeutics' CSO Ron Batra describes the company's FORCE platform, and previews big trial scheduled in DMD and DM1 over the next year - BiotechTV - News | Podcast on Spotify
    • charset
      utf-8
    • X-UA-Compatible
      IE=9
    • viewport
      width=device-width, initial-scale=1
    • fb:app_id
      174829003346

  • Open Graph Meta Tags

    154
    • og:site_name
      Spotify
    • og:title
      Benchtalk 2025: Dyne Therapeutics' CSO Ron Batra describes the company's FORCE platform, and previews big trial scheduled in DMD and DM1 over the next year
    • og:description
      BiotechTV - News · Episode
    • og:url
      https://open.spotify.com/episode/2SmuBfrn45mHyGx8mp6kFa
    • og:type
      music.song

  • Twitter Meta Tags

    5
    • twitter:site
      @spotify
    • twitter:title
      Benchtalk 2025: Dyne Therapeutics' CSO Ron Batra describes the company's FORCE platform, and previews big trial scheduled in DMD and DM1 over the next year
    • twitter:description
      BiotechTV - News · Episode
    • twitter:image
      https://image-cdn-ak.spotifycdn.com/image/ab6772ab0000169280414387d8a4995a7a0636fe
    • twitter:card
      summary

  • Link Tags

    31
    • alternate
      https://open.spotify.com/oembed?url=https%3A%2F%2Fopen.spotify.com%2Fepisode%2F2SmuBfrn45mHyGx8mp6kFa
    • alternate
      android-app://com.spotify.music/spotify/episode/2SmuBfrn45mHyGx8mp6kFa
    • canonical
      https://open.spotify.com/episode/2SmuBfrn45mHyGx8mp6kFa
    • icon
      https://open.spotifycdn.com/cdn/images/favicon32.b64ecc03.png
    • icon
      https://open.spotifycdn.com/cdn/images/favicon16.1c487bff.png

  • Website Locales

    2
    • EN country flagen
      https://open.spotify.com/episode/2SmuBfrn45mHyGx8mp6kFa
    • DEFAULT country flagx-default
      https://open.spotify.com/episode/2SmuBfrn45mHyGx8mp6kFa

Links

9